A level of confidence: beta-hydroxybutyrate and myocardial glucose uptake suppression on 18F-FDG PET imaging

被引：1
|
作者：
Osborne, Michael T. [1 ,2 ,6 ,7 ]
Qamar, Iqra [2 ,3 ]
Selvaraj, Senthil [4 ,5 ]
机构：
[1] Massachusetts Gen Hosp, Cardiovasc Imaging Res Ctr, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
[3] Massachusetts Gen Hosp, Cardiol Div, Boston, MA USA
[4] Duke Univ, Dept Med, Div Cardiol, Sch Med, Durham, NC USA
[5] Duke Univ, Duke Mol Physiol Inst, Durham, NC USA
[6] Massachusetts Gen Hosp, Cardiol Div, 55 Fruit St,Yawkey 5E, Boston, MA 02114 USA
[7] Harvard Med Sch, 55 Fruit St,Yawkey 5E, Boston, MA 02114 USA
来源：
JOURNAL OF NUCLEAR CARDIOLOGY | 2023年 / 30卷 / 03期
关键词：
D O I：
10.1007/s12350-023-03199-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：938 / 940
页数：3
相关论文
共 50 条
  • [1] A level of confidence: beta-hydroxybutyrate and myocardial glucose uptake suppression on 18F-FDG PET imaging
    Michael T. Osborne
    Iqra Qamar
    Senthil Selvaraj
    Journal of Nuclear Cardiology, 2023, 30 : 938 - 940
  • [2] The utility of beta-hydroxybutyrate in detecting myocardial glucose uptake suppression in patients undergoing inflammatory [18F]-FDG PET studies
    Alfawara, Moath Said
    Ahmed, Ahmed Ibrahim
    Saad, Jean Michel
    Han, Yushui
    Alahdab, Fares
    Al Rifai, Mahmoud
    Kassi, Mahwash
    Alnabelsi, Talal
    Zoghbi, William A.
    Al-Mallah, Mouaz H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (04) : 1103 - 1110
  • [3] The utility of beta-hydroxybutyrate in detecting myocardial glucose uptake suppression in patients undergoing inflammatory [18F]-FDG PET studies
    Moath Said Alfawara
    Ahmed Ibrahim Ahmed
    Jean Michel Saad
    Yushui Han
    Fares Alahdab
    Mahmoud Al Rifai
    Mahwash Kassi
    Talal Alnabelsi
    William A. Zoghbi
    Mouaz H. Al-Mallah
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 1103 - 1110
  • [4] Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading
    Brink, I
    Nitzsche, EU
    Mix, M
    Schindler, I
    Hentschel, M
    Högerle, S
    Moser, E
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2003, 42 (01): : 39 - 44
  • [5] Heparin does not improve myocardial glucose metabolism suppression in [18 F]FDG PET/CT in patients with low β-hydroxybutyrate level
    Hartikainen, Suvi
    Vepsalainen, Ville
    Laitinen, Tiina
    Hedman, Marja
    Laitinen, Tomi
    Tompuri, Tuomo
    EJNMMI RESEARCH, 2024, 14 (01):
  • [6] Noninvasive Measurement of Mouse Myocardial Glucose Uptake with 18F-FDG
    Buxton, Denis B.
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (05) : 866 - 866
  • [7] MANAGEMENT PRINCIPLES OF INCIDENTAL THYROID 18F-FDG UPTAKE IDENTIFIED ON 18F-FDG PET/CT IMAGING
    Akbas, A.
    Dagmura, H.
    Gul, S.
    Dasiran, F.
    Daldal, E.
    Okan, I
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2022, 18 (02) : 253 - 257
  • [8] Use of unfractionated heparin for the suppression of myocardial glucose metabolism in 18F-FDG PET/CT studies
    Suarez Fernandez, J. P.
    Gonzalez Garcia, F. M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2021, 40 (01): : 67 - 68
  • [9] Normal blood glucose level and 18F-FDG PET/CT
    Peiro Valganon, V.
    Alonso Farto, J. C.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2012, 31 (04): : 210 - 212
  • [10] The Impact of Blood Glucose Testing in 18F-FDG PET Imaging
    Adler, M.
    Holdgaard, P. C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S782 - S782
12345